The Vanguard Group 13D/13G Filings for Acorda Therapeutics, Inc. (ACOR)

The Vanguard Group 13D and 13G filings for Acorda Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-12-10
09:10 am
Sale
2020-11-30 13G Acorda Therapeutics, Inc.
ACOR
The Vanguard Group 18,845
4.720%
-23,185decrease
(-55.16%)
Filing